Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biogen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
BIIB
Nasdaq
2836
www.biogen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biogen Inc.
Biogen Announces Board Chair Transition
- Feb 11th, 2026 3:00 pm
Biogen Pipeline Advances In Lupus And SMA Reshape Growth Outlook
- Feb 10th, 2026 5:09 am
Why Biogen (BIIB) Is Up 8.2% After Mixed 2025 Earnings and Neurology Pipeline Updates – And What's Next
- Feb 9th, 2026 11:06 pm
Biogen Sales Execution, Growth Support Long-Term EPS, RBC Says
- Feb 9th, 2026 9:40 am
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts?
- Feb 9th, 2026 9:38 am
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
- Feb 8th, 2026 7:00 pm
Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump
- Feb 8th, 2026 3:31 pm
BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds
- Feb 6th, 2026 10:31 pm
Why Biogen Stock Surged Almost 9% Higher on Friday
- Feb 6th, 2026 6:07 pm
Biogen’s Nusinersen Data And FDA Review Put Valuation In Focus
- Feb 6th, 2026 3:06 pm
How One Drug Heavy-Lifted Biogen's Fourth-Quarter Beat
- Feb 6th, 2026 2:09 pm
Biogen Inc (BIIB) Q4 2025 Earnings Call Highlights: Strong Growth in Key Products Amidst ...
- Feb 6th, 2026 2:02 pm
Biogen stock pops, Robinhood gets lift as bitcoin ticks up
- Feb 6th, 2026 1:48 pm
Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio.
- Feb 6th, 2026 10:01 am
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
- Feb 6th, 2026 9:30 am
Biogen Forecasts 2026 Profit Above Estimates as Shares Climb 30%
- Feb 6th, 2026 9:15 am
Biogen (BIIB) Q4 2025 Earnings Call Transcript
- Feb 6th, 2026 8:29 am
Biogen Q4 Earnings Call Highlights
- Feb 6th, 2026 8:10 am
Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Feb 6th, 2026 7:30 am
Biogen Revenue Down as Multiple Sclerosis Sales Slide
- Feb 6th, 2026 6:59 am
Scroll